Who owns LANDOS BIOPHARMA INC?
- Ticker: LABP
- CUSIP Number: 515069201
Tip: Access positions for across all investors
Analyze quarterly positions in Landos Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Landos Biopharma stock
Who bought or sold LANDOS BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 1.5M | $32M | 0% | Mar 2024 |
|
| Deltec Asset Management | 50k | $1.1M | 100% | Mar 2024 |
|
| Virtu Financial | 15k | $313k | 100% | Mar 2024 |
|
| Geode Capital Management | 13k | $271k | 0% | Mar 2024 |
|
| Black Maple Capital Management | 10k | $224k | 100% | Mar 2024 |
|
| PenderFund Capital Management | 9.3k | $271k | 100% | Mar 2024 |
|
| UBS Group | 4.1k | $86k | 9624% | Mar 2024 |
|
| Tower Research Capital | 896.00 | $19k | -24% | Mar 2024 |
|
| Acadian Asset Management | 134.00 | $2.0k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 61.00 | $999.997400 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 59.00 | $1.3k | 0% | Mar 2024 |
|
| Morgan Stanley | 13.00 | $278.999500 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 10.00 | $215.000000 | 0% | Mar 2024 |
|
Who sold out of Landos Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Sep 2023 | 42.00 | $163.002000 |